Radioactive Iodine (I-131) Therapy for Thyroglobulin Positive, Scan Negative Differentiated Thyroid Cancer.

被引：0
|
作者：
Alzahrani, Ali S. [1 ]
Alshaikh, Omalkhaire [1 ]
Al-Shehri, Sameerah [1 ]
Farhat, Rafif [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of post-thyroidectomy I-123 versus I-131 Whole Body Scan on the outcome of radioactive iodine (I-131) ablation for differentiated thyroid carcinoma: A comparative study
    Sayed, M. H. M.
    Fadl, F. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S342 - S342
  • [32] Therapeutic efficacy of iodine-131-therapy in thyroid cancer patients with positive thyroglobulin but negative iodine-131 whole body scans
    Sahlmann, CO
    Meller, J
    Lehmann, K
    Schreiber, K
    Meyer, I
    Altenvoerde, G
    Becker, W
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1091 - 1091
  • [33] The first experience with Bexarotene in patients with I-131 negative differentiated thyroid cancer
    Stokkel, M. P. M.
    Smit, J. W.
    Verkooijen, R. B. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S111 - S111
  • [34] Results of individual maximal safe administered dose method of I-131 therapy in differentiated thyroid cancer.
    Kim, S
    Chung, JK
    So, Y
    Lee, DS
    Lee, MC
    Li, MH
    Bom, HS
    Song, HC
    Kim, SM
    Heo, YJ
    Kim, JY
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 175P - 175P
  • [35] Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer
    Kloos, Richard T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05): : 1519 - 1525
  • [36] THYROID CANCER AND THERAPY WITH I-131
    PIERS, DA
    LANCET, 1976, 2 (7981): : 373 - 373
  • [37] Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed
    Ito, S.
    Iwano, S.
    Kato, K.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S600 - S601
  • [38] 18F-FDG PET in the Management of Differentiated Thyroid Cancer in Patients with High Serum Thyroglobulin and Negative I-131 Whole Body Scan.
    Martins, R. G.
    Santos, A. P.
    Couto, J.
    Barbosa, A. P.
    Teixeira, J.
    Lucena, I.
    Bastos, L.
    Torres, I.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [39] RECURRENT THYROID-CANCER ROLE OF SURGERY VERSUS RADIOACTIVE IODINE (I-131)
    COBURN, M
    TEATES, D
    WANEBO, HJ
    ANNALS OF SURGERY, 1994, 219 (06) : 587 - 595
  • [40] Usefulness of Iodine 123 ( I-123 ) in Evaluation of Patients with Differentiated Thyroid Carcinoma before Therapy with Iodine 131 ( I-131 )
    Tsilomeleti, I.
    Koutsouba, T.
    Vonorta, K.
    Kalogeropoulos, K.
    Papoutsis, V.
    Plataniotis, N.
    Stromatia, F.
    Nikolopoulou, M.
    Oros, L.
    Anapliotou, M.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S240 - S241
12345